This doctor wants the new HIV drug to be available to every South African
Dr. Tom Ellman of Doctors Without Borders discusses the need for equitable access to the new HIV prevention drug, Lenacapavir. The conversation highlights the challenges posed by pharmaceutical patents and pricing in ensuring that life-saving medical breakthroughs reach underserved populations.
Why it matters
The debate over access to Lenacapavir underscores the broader global struggle to balance pharmaceutical innovation with public health needs in developing nations.
In Episode 15 of The Odds in Our Favour , Saskia Falken chats to Dr Tom Ellman of Doctors Without Borders about the new HIV prevention breakthrough, Lenacapavir, and asks: “Who will actually get it?”
The article focuses on the advocacy of a medical organization while framing the issue as a question of equitable access.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in